[THE ANTITUBERCULOSIS CHEMOPROPHYLAXIS BY ISONIAZID IN HUMANS AND CATTLE].
D000818:Animals; D000995:Antitubercular Agents; D001500:BCG Vaccine; D002417:Cattle; D018890:Chemoprevention; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007538:Isoniazid / Q000633:toxicity*; D008660:Metabolism; D051379:Mice; D009163:Mycobacterium bovis; D010600:Pharmacology; D011315:Preventive Medicine; D011736:Pyridoxine; D011817:Rabbits; D012829:Silicosis; D014376:Tuberculosis / Q000276:immunology*; D014380:Tuberculosis, Bovine; D014611:Vaccination
D000995:Antitubercular Agents; D001500:BCG Vaccine; D011736:Pyridoxine; D007538:Isoniazid
BCG VACCINATION; CATTLE; DRUG RESISTANCE, MICROBIAL; DRUG TOLERANCE; GUINEA PIGS; ISONIAZID; ISONIAZID TOXICOLOGY; METABOLISM; MICE; MONKEYS; PHARMACOLOGY; PREVENTIVE MEDICINE; PYRIDOXINE; RABBITS; SILICOSIS; TUBERCULOSIS; TUBERCULOSIS IMMUNITY; TUBERCULOSIS, BOVINE